BioPharmGuy logo
Sponsored By:
Sponsorship Available
Purchase the BioPharmGuy data
Sinclair Research
TangenX is defunct.

Fate: Acquired by Novasep 2006, sold to Repligen, Dec 2016, $39M


------------------
If you believe any of this information is incorrect, please let us know.